Criminal Policy of Netherlands and U.S.A on Decriminalization of Soft Drugs justifications for decriminalization of soft dugs
Bioethics and Health Law Journal (BHL),
Vol. 1 No. 1 (2021),
30 November 2021
,
Page 1-10 (e11)
https://doi.org/10.22037/bhl.v1i1.38155
Abstract
Background and Aim: Soft drugs are those drugs that are very weak in terms of addiction and the effects are highly treatable. The challenging issue regarding this type of drug is the decriminalization of its use. The criminal policy of some countries such as the Netherlands agrees with the decriminalization and the criminal policy of many others such as the United States of America is against it.
Materials and Methods: To review the reasons and justifications of each of parties for and against soft drug decriminalization, ideas of lawyers and scientific studies in the Netherland and the United States have been considered, and criminal poly makers’ ideas will be reviewed.
Ethical Considerations: Honesty in the literature and citation analysis and reporting were considered.
Findings To justify soft drug criminalization, two classifications of legal and health reasons and justifications can be cited. Legally, it has been stated that drug issue is a problem related to the health and treatment domain, and criminal legal intervention in this area must be considered just as the last weapon. In addition, Penologically, punishing soft drug users is unnecessary, ineffective, without favor, and unnecessary. Regarding health, it has been stated that not only using some soft drugs such as cannabis is not the reason for being sick, but also it has an effective role in treating incurable diseases such as multiple sclerosis, AIDS, hepatitis, chronic pain, and ….
Conclusion: Decriminalization of soft drugs has a theoretical and practical background in countries such as the Netherlands and the United States. Soft drugs like cannabis not only have a lower degree of addictive rate rather than Hard drugs like heroin, but also it has some therapeutic benefits. Legally, the decriminalization of soft drugs has roots in human rights, penology, and criminological justifications.
*Corresponding Author: Seyed Reza Ehsanpour; Email: ehssanpour@shahed.ac.ir; ORCID: https://orcid.org/0000-0001-9135-3968
Please cite this article as: Ehsanpour SR. Criminal Policy of Netherlands and U.S.A on Decriminalization of Soft Drugs. Bioeth Health Law J. 2021; 1: 1-0 (e11). http://doi.org/10.22037/bhl.v1i1.38155
- Soft Drugs
- Cannabis
- Decriminalization
- Netherlands
- The United States
How to Cite
References
Abbasi M, Rezaee R, Dehghani G. Concept and situation of the right to health in Iran legal system. Iranian Journal of Medical Law. 2014 Oct 10;8(30):183-99.
Abbasi M, Petoft A. Citizenship rights, from Principles to social Platform. Tehran: Legal Publishers. 2017:85.
Weldy EW, Stanley J, Koduri VA, McCourt EA, Patnaik JL, Kahook MY, Seibold LK. Perceptions of Marijuana Use for Glaucoma from Patients, Cannabis Retailers, and Glaucoma Specialists. Ophthalmology Glaucoma. 2020 Nov 1;3(6):453-9.
Dukes AJ, Fowler JP, Lallai V, Pushkin AN, Fowler CD. Adolescent cannabinoid and nicotine exposure differentially alters adult nicotine self-administration in males and females. Nicotine and Tobacco Research. 2020 Aug;22(8):1364-73.
Abassi M, Petoft A. Fundamentals of Neurolaw. Tehran: Medical Ethics and Law Research Center, Shahid Beheshti University of Medical Sciences. 2019.
Engelsman, E.L. Drug Policy in the Netherlands. Paper prepared for the American Embassy in the Netherlands, the Ministry of Welfare, Health and Cultural Affairs; Alcohol, Drugs and Tobacco Branch; 1988. P. 37
Abbasian L, Abbasi M, SHAMSI GE, NASERI RM, Memariani Z. Survey on the scientific position of the spiritual health and its role in preventing from diseases: A preliminary study. 2011.
Fergusson, D. M. & Horwood, L. J. Does cannabis use encourage other forms of illicit drug use?, Addiction; 2000.p. 95.
Van Ours, J. C. Is Cannabis A Stepping-Stone For Cocaine? Journal of Health Economics; 2003. P. 22.
Coffey, C., Lynskey, M., Wolfe, R. & Patton, G. C. Initiation and progression of cannabis use in a population-based Australian adolescent study, Addiction; 2000.p. 95.
Petoft A. The Validation Requirments of Neurscientific Evidences before Courts. Iranian Journal of Medical Law. 2021 Apr 10;15(56):431-43.
Petoft A, Abasi M. Citizenship Rights: from the Government Protection to Monitoring on it. Tehran: Justice Publication. 2017:59-65.
Hajiesmaeili MR, Abbasi M, Jafari NJ, Abdoljabari M, Fani M, Mesri M, Baghernezhad F, Shahosseini AA, Azimi AV. Spiritual health concept: A hybridized study. Medical History Journal. 2016;6(21):15-49.
Lopez MJ, Nataneli N. Cannabis Use For Glaucoma And Associated Pain. StatPearls [Internet]. 2021 Jun 21.
Merritt, J. Effects of Topical Delta-9-Tetrahydrocannabinol On Intraocular Pressure In Dogs. Glaucoma; 1981. P.21.
Merritt, J., Olsen J., Armstrong, J. and McKinnon, S. Topical Delta-9-Tetrahydrocannabinol in hypertensive glaucomas. J. Phar. Pharmacol; 1981. P. 33.
Passani A, Posarelli C, Sframeli AT, Perciballi L, Pellegrini M, Guidi G, Figus M. Cannabinoids in Glaucoma Patients: The Never-Ending Story. Journal of clinical medicine. 2020 Dec;9(12):3978.
Merritt, J., Cook, C. and Davis, K. Orthostatic Hypotension after Delta-9- Tetrahydrocannabinol Marihuana Inhalation. Ophthalmic Res; 1982. P. 14.
Abbasi M, Rezaee R, Dehghani G. Concept and situation of the right to health in Iran legal system. Iranian Journal of Medical Law. 2014 Oct 10;8(30):183-99.
Merritt, J. Outpatient Cannabinoid Therapy For Heterogenous Glaucomas: Guidelines for institution and maintenance of therapy. Marijuana 84: Proceedings of the Oxford Symposium on Cannabis; 1984. P.87.
Petoft A, Abbasi M. Current limits of neurolaw: A brief overview. Médecine & Droit. 2020 Apr 1;2020(161):29-34.
Goldberg, I., Kass, M. and Becker, B. Marijuana as a Treatment for Glaucoma. Sightsaving Review, winter issue; 1979. P.54.
Petoft A. An Overview of the Technical Limitations of Applying the fMRI Method in Neurolaw. Bioethics Journal. 2019;9(34):95-107.
Petoft A. Neurolaw: A brief introduction. Iranian journal of neurology. 2015 Jan 5;14(1):53.
Petoft A. The Use of Neuroscientific Evidence in the Modern Criminal Law with Emphasizing on the UK and Canadian Neurolitigation. Iranian Journal of Medical Law. 2021 Apr 10;15(56):241-59.
Donald Tashkin, M.D. Study Finds No Link between Marijuana Use and Lung Cancer., Science Daily; 2006.p.12.
Petoft A, Momeni-Rad A. Toward Human Behavior Sciences from the Perspective of Neurolaw. International Journal of Public Mental Health and Neuroscience. 2015;2(2):29-33.
Hayes JS, Lampart R, Dreher MC, Morgan L. Five-Year Follow-Up Of Rural Jamaican Children Whose Mothers Used Marijuana During Pregnancy. The West Indian Medical Journal; 1991.p. 40.
Petoft A, Abbasi M. A historical overview of law and neuroscience: From the emergence of medico-legal discourses to developed neurolaw. Archivio Penale. 2019;1(2):1-48.
Day, N. L., Richardson, G. A., Goldschmidt, L., Robles, N., Taylor, P. M., Stoffer, D. S., Cornelius, M. D. & Geva, D. Effect of prenatal marijuana exposure on the cognitive development of offspring at age three, Neurotoxicology & Teratology; 1994.p. 16.
Petoft A. Concept and scope of the general principles of administrative law and referring possibility in the judicial procedure. The Judiciary Research Institute Publishing Center.2016.
Fried P, Watkinson B, James D, Gray R. Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults. CMAJ ; 2002.p.166.
Fried PA, Watkinson B, Gray R. Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicology and Teratology; 2003.p 25.
Degenhardt L, Hall W, Lynskey M. Comorbidity between cannabis use and psychosis: Modelling some possible relationships. Technical Report No. 121. Sydney: National Drug and Alcohol Research Centre;2001. p.128.
Zuardi, A.W; J.A.S. Crippa, J.E.C. Hallak, F.A. Moreira, F.S. Guimarães. Cannabidiol as an antipsychotic drug. Brazilian Journal of Medical and Biological Research; 2006. P. 39 .
Leweke, F. M. ; Koethe, D. ; Pahlisch, F. ; Schreiber, D. ; Gerth, C. W. ; Nolden, B. M. ; Klosterkötter, J. ; Hellmich, M. Antipsychotic Effects of Cannabidiol". European Psychiatry ;2009. P.27.
Groh CJ. Medical Cannabis and Psychiatric Disorders: Implications for Psychiatric Nurses. Journal of the American Psychiatric Nurses Association. 2020 Aug 8:1078390320945791.
Schwenk, C. R. Marijuana and job performance: Comparing the major streams of research, Journal of Drug Issues; 1998. P. 28.
Vinciguerra, V. Inhalation Marijuana as an Antiemetic for Cancer Chemotherapy, New York State Journal of Medicine; 1988. P.82.
Vijhe MR, Petoft A. A Foucauldian Analysis of Post-Modern Concept of Sovereignty in the Light of Public Law. The Quartely Journal of Public Law. 2016;18(52):9-32.
Nelson, K. A Phase II Study of Delta-9-Tetrahydrocannabinol for Appetite Stimulation in Cancer-Associated Anorexia, Journal of Palliative Care; 1994. P. 10.
Abbasi M, Petoft A. Citizenship Rights: from Good Governance to Administrative Procedures. Tehran: Justice Publication. 2017:205-6.
Abrams DI, Vizoso HP, Shade SB, Jay C, Kelly ME, Benowitz NL . Vaporization as a Smokeless Cannabis Delivery System: A Pilot Study. Clinical Pharmacology and Therapeutics. 2007.p. 82.
De Jong, B.D. Marijuana Use and Its Association with Adherence to Antiretroviral Therapy among HIV-Infected Persons With Moderate to Severe Nausea, Journal of Acquired Immune Deficiency Syndromes; 2005.p. 38.
Haney, M. e. Dronabinol and Marijuana in HIV-Positive Marijuana Smokers. Caloric Intake, Mood, and Sleep, Journal of Acquired Immune Deficiency Syndromes; 2007.p. 45.
Sylvestre, D.L., Clements, B.J. and Malibu, Y. Cannabis Use Improves Retention and Virological Outcomes in Patients Treated For Hepatitis C, European Journal of Gastroenterology and Hematology; 2006. P. 18.
Fischer, B. Treatment For Hepatitis C Virus and Cannabis use in Illicit Drug User Patients: Implications and Questions,” European Journal of Gastroenterology and Hepatology; 2006.p. 18.
Petoft A, Vijeh M. The evolution of government intervention in the economy from the perspective of public law, welfare to post regulatory governments. The quarterly journal of public law research. 2015;17(47):190-8.
Abrams D, Cannabis in Painful HIV-Associated Sensory Neuropathy: a Randomized Placebo-Controlled Trial, Neurology; 2007.p. 68
Ellis, . R.J. Smoked Medicinal Cannabis For Neuropathic Pain in HIV: a Randomized, Crossover Clinical Trial, Neuropsychopharmacology; 2009.p. 34.
Wilsey, B. A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain,” Journal of Pain; 2008. P. 9.
Lynch, M.E. Young, J. Clark, A.J. A Case Series of Patients Using Medicinal Marihuana for Management of Chronic Pain Under the Canadian Marihuana Medical Access Regulations, Journal of Pain and Symptom Management; 2006. P. 32.
Zajicek, J. Cannabinoids for Treatment of Spasticity and Other Symptoms Related to Multiple Sclerosis (CAMS Study): Multicentre Randomised Placebo-Controlled Trial, The Lancet; 2003. P. 362.
Wade, D.T. Long-Term Use of a Cannabis-Based Medicine in the Treatment of Spasticity and Other Symptoms in Multiple Sclerosis. Multiple Sclerosis; 2006. P. 12.
Layeeque, R. Prevention of Nausea and Vomiting Following Breast Surgery, American Journal of Surgery; 2006. P. 191.
Petoft A. Controversial Brain Imaging as a Terrorism Emergency Measure in Neurolaw Discourse. Journal of Neurology & Neurotherapy. 2017;2(2):1-9.
Hajiesmaeili MR, Abbasi M, Safaiepour L, Fani M, Abdoljabari M, Hosseini SM, Baghernezhad F, Shahosseini A, Akrami F, VAHEDIAN AA. Spiritual health concept in Iranian society: Evolutionary concept analysis and narrative review. 2016.
Walther, S. Delta-9-Tetrahydrocannabinol for Nighttime Agitation in Severe Dementia, Psychopharmacology (Berl); 2006. P. 185.
Esposito, G. The Marijuana Component Cannabidiol Inhibits Beta-Amyloid-Induced Tau Protein Hyperphosphorylation Through Wnt/beta-catenin Pathway Rescue in PC12 Cells,” Journal of Molecular Medicine; 2006.p. 84.
- Abstract Viewed: 73 times
- PDF Downloaded: 25 times